At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 606 enrolled
Drug / intervention
Chondroitin/Glucosamine (Droglican) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non-Inferiority Clinical Trial On The Efficacy And Safety Of Chondroitin Sulfate And Glucosamine Hydrochloride In Combination Versus Celecoxib In Patients With Knee Osteoarthritis
In Brief
A Phase 4 clinical trial evaluating Chondroitin/Glucosamine (Droglican) and Celecoxib for Knee Osteoarthritis. Completed, enrolled 606 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether the combination of Chondroitin sulfate (CS) and Glucosamine Hydrochloride (GH) has similar efficacy to Celecoxib (CE) in the treatment of patients with moderate to severe knee osteoarthritis (OA).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKnee Osteoarthritis
CountriesSpain
Collaborators--
Timeline
Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedAug 2011
Enrollment StartSep 2011
Primary CompletionApr 2013
Study CompletionMay 2013
TodayJul 2026
First PostedAug 30, 2011
Enrollment StartSep 1, 2011
Primary CompletionApr 1, 2013
Study CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 14.8 years ago
Interventions
Chondroitin/Glucosamine (Droglican)drug
Experimental
Celecoxibdrug
Active comparator